Wu Y - Search Results

1

Exosomes in development, metastasis and drug resistance of breast cancer.

Yu DD, Wu Y, Shen HY, Lv MM, Chen WX, Zhang XH, Zhong SL, Tang JH, Zhao JH. Yu DD, et al. Among authors: wu y. Cancer Sci. 2015 Aug;106(8):959-64. doi: 10.1111/cas.12715. Epub 2015 Jul 20. Cancer Sci. 2015. PMID: 26052865 Free PMC article. Review.

2

Exosomes from adriamycin-resistant breast cancer cells transmit drug resistance partly by delivering miR-222.

Yu DD, Wu Y, Zhang XH, Lv MM, Chen WX, Chen X, Yang SJ, Shen H, Zhong SL, Tang JH, Zhao JH. Yu DD, et al. Among authors: wu y. Tumour Biol. 2016 Mar;37(3):3227-35. doi: 10.1007/s13277-015-4161-0. Epub 2015 Oct 2. Tumour Biol. 2016. PMID: 26432333

3

Liver X receptor as a drug target for the treatment of breast cancer.

Wu Y, Yu DD, Yan DL, Hu Y, Chen D, Liu Y, Zhang HD, Yu SR, Cao HX, Feng JF. Wu Y, et al. Anticancer Drugs. 2016 Jun;27(5):373-82. doi: 10.1097/CAD.0000000000000348. Anticancer Drugs. 2016. PMID: 26872310 Review.

4

MiRNAs-mediated cisplatin resistance in breast cancer.

Chen X, Lu P, Wu Y, Wang DD, Zhou S, Yang SJ, Shen HY, Zhang XH, Zhao JH, Tang JH. Chen X, et al. Among authors: wu y. Tumour Biol. 2016 Oct;37(10):12905-12913. doi: 10.1007/s13277-016-5216-6. Epub 2016 Jul 22. Tumour Biol. 2016. PMID: 27448297 Review.

5

The role of miRNAs in drug resistance and prognosis of breast cancer formalin-fixed paraffin-embedded tissues.

Chen X, Lu P, Wang DD, Yang SJ, Wu Y, Shen HY, Zhong SL, Zhao JH, Tang JH. Chen X, et al. Among authors: wu y. Gene. 2016 Dec 31;595(2):221-226. doi: 10.1016/j.gene.2016.10.015. Epub 2016 Oct 13. Gene. 2016. PMID: 27746365

6

MiR-139-5p inhibits the biological function of breast cancer cells by targeting Notch1 and mediates chemosensitivity to docetaxel.

Zhang HD, Sun DW, Mao L, Zhang J, Jiang LH, Li J, Wu Y, Ji H, Chen W, Wang J, Ma R, Cao HX, Wu JZ, Tang JH. Zhang HD, et al. Among authors: wu y, wu jz. Biochem Biophys Res Commun. 2015 Oct 2;465(4):702-13. doi: 10.1016/j.bbrc.2015.08.053. Epub 2015 Aug 20. Biochem Biophys Res Commun. 2015. PMID: 26299922

7

LXR ligands sensitize EGFR-TKI-resistant human lung cancer cells in vitro by inhibiting Akt activation.

Wu Y, Yu DD, Hu Y, Cao HX, Yu SR, Liu SW, Feng JF. Wu Y, et al. Biochem Biophys Res Commun. 2015 Nov 27;467(4):900-5. doi: 10.1016/j.bbrc.2015.10.047. Epub 2015 Oct 21. Biochem Biophys Res Commun. 2015. PMID: 26471306

8

Genome-wide profiling of long non-coding RNA expression patterns in the EGFR-TKI resistance of lung adenocarcinoma by microarray.

Wu Y, Yu DD, Hu Y, Yan D, Chen X, Cao HX, Yu SR, Wang Z, Feng JF. Wu Y, et al. Oncol Rep. 2016 Jun;35(6):3371-86. doi: 10.3892/or.2016.4758. Epub 2016 Apr 20. Oncol Rep. 2016. PMID: 27108960

9

WITHDRAWN: The long non-coding RNA, LINC00635-001, sensitizes EGFR-TKI-resistant human lung cancer cells in vitro by inhibiting Akt activation.

Wu Y, Yu DD, Hu Y, Yan DL, Chen X, Zhang HD, Cao HX, Yu SR, Wang Z, Feng JF. Wu Y, et al. Biochem Biophys Res Commun. 2016 Jan 11:S0006-291X(16)30057-2. doi: 10.1016/j.bbrc.2016.01.057. Online ahead of print. Biochem Biophys Res Commun. 2016. PMID: 26792719

10

The Prognostic Value of Neutrophil-to-lymphocyte Ratio and Monocyte-to-lymphocyte Ratio in Metastatic Gastric Cancer Treated with Systemic Chemotherapy.

Zhou D, Wu Y, Zhu Y, Lin Z, Yu D, Zhang T. Zhou D, et al. Among authors: wu y. J Cancer. 2020 Apr 25;11(14):4205-4212. doi: 10.7150/jca.39575. eCollection 2020. J Cancer. 2020. PMID: 32368303 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

86,030 results

Search Page

Filters